tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co (JP:4521)
:4521

Kaken Pharmaceutical Co (4521) Revenue

Compare
0 Followers

Kaken Pharmaceutical Co Revenue

Kaken Pharmaceutical Co had a revenue of 18.87B in the quarter ending Jun 30, 2025, with 4.56%. This bring the company's revenue in the last twelve months to 94.65B, Decreased 0.65%. In the fiscal year ending Dec 31, 2025, Kaken Pharmaceutical Co had annual revenue of 94.03B with 30.52% growth.
Revenue (ttm)
94.65B
Revenue Growth
-5.99%
P/S Ratio
1.54
Revenue/Employee
¥82,850,220
Employees
1,135
Market Cap
¥144.80B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
94.03B21.99B+130.52%
Dec 31, 2024
72.04B-940.00M+98.71%
Dec 31, 2023
72.98B-3.05B+95.99%
Dec 31, 2022
76.03B1.05B+101.41%
Dec 31, 2021
74.98B-14.26B+84.03%
Dec 31, 2020
89.23B-4.93B+94.76%
Dec 31, 2019
94.17B-4.26B+95.67%
Dec 31, 2018
98.43B-3.56B+96.51%
Dec 31, 2017
101.99B-7.23B+93.38%
Dec 31, 2016
109.22B